What is the price target for FCNCA stock?
22 analysts have analysed FCNCA and the average price target is 2342.69 USD. This implies a price increase of 24.95% is expected in the next year compared to the current price of 1874.89.
NASDAQ:FCNCA • US31946M1036
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FIRST CITIZENS BCSHS -CL A (FCNCA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-29 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-01-27 | Truist Securities | Maintains | Hold -> Hold |
| 2026-01-26 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-26 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-26 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-30 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-12-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-05 | UBS | Maintains | Buy -> Buy |
| 2025-10-28 | Truist Securities | Maintains | Hold -> Hold |
| 2025-10-27 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-10-24 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-10-24 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-24 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-10-06 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-03 | Truist Securities | Maintains | Hold -> Hold |
| 2025-07-28 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-07-02 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-07-01 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-21 | Jefferies | Initiate | Hold |
| 2025-04-25 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-03-18 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-03-11 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2025-01-29 | Truist Securities | Maintains | Hold -> Hold |
| 2025-01-27 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 18.787B 269.68% | 9.758B -48.06% | 9.541B -2.22% | 9.522B -0.20% | 9.967B 4.67% | 10.462B 4.97% | N/A | N/A | N/A | N/A | N/A | |
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | N/A 136.62% | N/A -0.48% | N/A -19.29% | 3.468B -0.72% | 3.696B 6.57% | 3.535B -4.36% | 4.139B 17.09% | 4.294B 3.74% | 4.458B 3.82% | 4.614B 3.50% | 4.784B 3.68% | |
| Operating Margin | N/A | N/A | N/A | 36.42% | 37.08% | 33.79% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 175.19 144.24% | 194.76 11.17% | 169.04 -13.21% | 181.87 7.59% | 208.01 14.37% | 229.55 10.35% | 255.32 11.23% | 280.32 9.80% | 308.37 10.01% | 337.62 9.49% | 360.86 6.88% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 40.69 7.68% | 44.67 5.46% | 49.85 15.71% | 52.65 14.93% | 48.32 18.76% | 52.95 18.53% | 56.09 12.51% | 57.52 9.25% |
| Revenue Q2Q % growth | 2.315B 0.74% | 2.348B -1.05% | 2.427B -0.25% | 2.469B 1.31% | 2.422B 4.62% | 2.471B 5.24% | 2.516B 3.67% | 2.547B 3.16% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 819.54M -11.31% | 868.81M -4.55% | 909.6M -2.78% | 963.73M 4.06% | 824.93M 0.66% | 878.28M 1.09% | 903.72M -0.65% | 914.43M -5.12% |
All data in USD
22 analysts have analysed FCNCA and the average price target is 2342.69 USD. This implies a price increase of 24.95% is expected in the next year compared to the current price of 1874.89.
FIRST CITIZENS BCSHS -CL A (FCNCA) will report earnings on 2026-04-22.
The consensus EPS estimate for the next earnings of FIRST CITIZENS BCSHS -CL A (FCNCA) is 40.69 USD and the consensus revenue estimate is 2.31B USD.
The number of analysts covering FIRST CITIZENS BCSHS -CL A (FCNCA) is 22.